Vol 55, No 2 (2017)
Original paper
Published online: 2017-06-20
The role of homocysteine in seminal vesicles remodeling in rat
Abstract
Introduction. Elevated plasma homocysteine (Hcy) levels have been associated with several tissue injuries including heart and liver fibrosis. In these diseases, hyperhomocysteinemia (Hhcy) plays a major role in modulating the alteration of the balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMPs), leading to the pathological accumulation of extracellular matrix (ECM) proteins. Since the effect of Hhcy on ECM of seminal vesicle was not studied, the aim of our research was to check if Hcy can induce a remodeling within seminal vesicles ECM.
Material and methods. The study was conducted in 22 adult male Wistar rats. The rats were divided into two groups: a control group, which received standard diet and tap water; the treated group received the same diet and water supplemented with solution of L-methionine (200 mg/kg b.w./day) for 6 months. Plasma homocysteine concentration was measured. Histological changes were observed with light microscope. The presence of collagen I and III and metalloproteinases (2, 3, 7 and 9) in the seminal vesicles was examined using immunohistochemistry and Western blotting.
Results. Plasma Hcy levels increased significantly after methionine treatment and interfered significantly with body weight in treated rats. The content of fibrillar collagens (I and III) in the wall of seminal vesicles was elevated in hyperhomocysteinemic rats. Moreover, we found that hyperhomocysteinemia increased the expression of MMP-2, -3, -7 and -9 in seminal vesicles of experimental rats.
Conclusions. Increased plasma concentration of Hcy accompanied by the accumulation of collagen and upregulation of MMPs in rat seminal vesicles might contribute to the remodeling of seminal vesicles.
Keywords: hyperhomocysteinemiaratseminal vesiclesmetalloproteinasescollagen Icollagen IIIIHCWestern blot
References
- Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost. 2000; 26(3): 219–225.
- Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995; 274(13): 1049–1057.
- Bukharaeva E, Shakirzyanova A, Khuzakhmetova V, et al. Homocysteine aggravates ROS-induced depression of transmitter release from motor nerve terminals: potential mechanism of peripheral impairment in motor neuron diseases associated with hyperhomocysteinemia. Front Cell Neurosci. 2015; 9: 391.
- Xie Di, Yuan Y, Guo J, et al. Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults. Sci Rep. 2015; 5: 16268.
- Mendes RH, Mostarda C, Candido GO, et al. Moderate hyperhomocysteinemia provokes dysfunction of cardiovascular autonomic system and liver oxidative stress in rats. Auton Neurosci. 2014; 180: 43–47.
- Li JJ, Li Q, Du HP, et al. Homocysteine triggers inflammatory responses in macrophages through inhibiting CSE-H2S signaling via DNA hypermethylation of CSE promoter. Int J Mol Sci. 2015; 16(6): 12560–12577.
- Matté C, Stefanello FM, Mackedanz V, et al. Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci. 2009; 27(4): 337–344.
- Pushpakumar S, Kundu S, Narayanan N, et al. DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney. FASEB J. 2015; 29(11): 4713–4725.
- Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999; 274(31): 21491–21494.
- Chakrabarti S, Patel KD. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 2005; 31(6): 599–621.
- Collier IE, Wilhelm SM, Eisen AZ, et al. H-ras Oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem. 1988; 263: 5579–6587.
- Lewkowicz J, Knapp M, Tankiewicz-Kwedlo A, et al. MMP-9 in atrial remodeling in patients with atrial fibrillation. Ann Cardiol Angeiol (Paris). 2015; 64(4): 285–291.
- Giannandrea M, Parks WC. Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech. 2014; 7(2): 193–203.
- Johansson N, Saarialho-Kere U, Airola K, et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Develop Dyn. 1997; 208(3): 387–397, doi: 10.1002/(sici)1097-0177(199703)208:3<387::aid-aja9>3.0.co;2-e.
- Li Jr, Shen T, Wang Yl, et al. Expression of matrix metalloproteinases and ovarian morphological changes in androgenized cyclic female guinea pigs. Tissue Cell. 2016; 48(1): 72–80.
- Farina AR, Cappabianca L, DeSantis G, et al. Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. FEBS Lett. 2011; 585(20): 3328–3336.
- Chang JH, Huang YH, Cunningham CM, et al. Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea. Surv Ophthalmol. 2016; 61(4): 478–497.
- Nguyen AH, Wang Y, White DE, et al. MMP-mediated mesenchymal morphogenesis of pluripotent stem cell aggregates stimulated by gelatin methacrylate microparticle incorporation. Biomaterials. 2016; 76: 66–75.
- Gaide Chevronnay HP, Selvais C, Emonard H, et al. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Biochim Biophys Acta. 2012; 1824(1): 146–156.
- Zhang X, Wang HM, Lin HY, et al. Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide. Placenta. 2004; 25(4): 243–252.
- Balbı́n M, Fueyo A, Knäuper V, et al. Analysis of its potential role in postpartum involution of the uterus. J Biol Chem. 1998; 273: 23959–23968.
- Ferrer M, Rodriguez H, Zara L, et al. MMP2 and acrosin are major proteinases associated with the inner acrosomal membrane and may cooperate in sperm penetration of the zona pellucida during fertilization. Cell Tissue Res. 2012; 349(3): 881–895.
- Slongo ML, Zampieri M, Onisto M. Expression of matrix metalloproteases (MMP-2, MT1 -MMP) and their tissue inhibitor (TIMP-2) by rat sertoli cells in culture: implications for spermatogenesis. Biol Chem. 2002; 383(1): 235–239.
- Tentes I, Asimakopoulos B, Mourvati E, et al. Matrix metalloproteinase (MMP)-2 and MMP-9 in seminal plasma. J Assist Reprod Genet. 2007; 24(7): 278–281.
- Belhocine M, Gernigon-Spychalowicz T, Robert AM, et al. Ecophysiological responses of the seminal vesicle of Libyan jird (Meriones libycus) to the Saharan conditions: histological, morphometric and immunohistochemical analysis. Histol Histopathol. 2007; 22(6): 603–615.
- Raaf L, Noll C, Cherifi ME, et al. Myocardial fibrosis and TGFB expression in hyperhomocysteinemic rats. Mol Cell Biochem. 2011; 347(1-2): 63–70.
- Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem. 1995; 41(7): 991–994.
- Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979; 11(4): 447–455.
- Mowry RW. Alcian blue techniques for the histochemical study of acidic carbohydrates. J Histochem Cytochem. 1956; 4: 407–408.
- Gabe M. Techniques histologiques: chapitre 15, Detection histochimiques des aldéhydes et cétones. Ed Masson et Cie, Paris 1968: p368.
- Suszyńska-Zajczyk J, Utyro O, Jakubowski H. Methionine-induced hyperhomocysteinemia and bleomycin hydrolase deficiency alter the expression of mouse kidney proteins involved in renal disease. Mol Genet Metab. 2014; 112(4): 339–346.
- Basu A, Jenkins AJ, Stoner JA, et al. DCCT/EDIC Research Group. Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study. Atherosclerosis. 2014; 236(1): 188–195.
- Joseph J, Washington A, Joseph L, et al. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol. 2002; 283(6): H2567–H2574.
- Matté C, Stefanello FM, Mackedanz V, et al. Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci. 2009; 27(4): 337–344.
- Fukada Si, Shimada Y, Morita T, et al. Suppression of methionine-induced hyperhomocysteinemia by glycine and serine in rats. Biosci Biotechnol Biochem. 2006; 70(10): 2403–2409.
- Bellamy MF, McDowell IF, Ramsey MW, et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation. 1998; 98(18): 1848–1852.
- Yalçinkaya S, Unlüçerçi Y, Giriş M, et al. Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine. Nutrition. 2009; 25(4): 436–444.
- Sharma M, Rai SK, Tiwari M, et al. Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats. Eur J Pharmacol. 2007; 574(1): 49–60.
- Xu Y, Tian Ye, Wei HJ, et al. Methionine diet-induced hyperhomocysteinemia accelerates cerebral aneurysm formation in rats. Neurosci Lett. 2011; 494(2): 139–144.
- Joseph J, Kennedy RH, Devi S, et al. Protective role of mast cells in homocysteine-induced cardiac remodeling. Am J Physiol Heart Circ Physiol. 2005; 288(5): H2541–H2545.
- Cao Lu, Lou X, Zou Z, et al. Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats. Microvasc Res. 2013; 89: 146–152.
- Tan H, Shi C, Jiang X, et al. Hyperhomocysteinemia promotes vascular remodeling in vein graph in mice. Front Biosci (Landmark Ed). 2014; 19: 958–966.
- Tyagi N, Sedoris KC, Steed M, et al. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol. 2005; 289(6): H2649–H2656.
- Kundu S, Tyagi N, Sen U, et al. Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Mol Cell Biochem. 2009; 332(1-2): 215–224.
- Nuttall RK, Sampieri CL, Pennington CJ, et al. Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. FEBS Lett. 2004; 563(1-3): 129–134.
- Nguyen AH, Wang Y, White DE, et al. MMP-mediated mesenchymal morphogenesis of pluripotent stem cell aggregates stimulated by gelatin methacrylate microparticle incorporation. Biomaterials. 2016; 76: 66–75.
- Walter I, Schönkypl S. Extracellular matrix components and matrix degrading enzymes in the feline placenta during gestation. Placenta. 2006; 27(2-3): 291–306.
- Grünwald B, Vandooren J, Locatelli E, et al. Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. J Control Release. 2016; 239: 39–48.
- Kim SH, Song YS, Hwang SY, et al. Effects of hormones on the expression of matrix metalloproteinases and their inhibitors in bovine spermatozoa. Asian-Australas J Anim Sci. 2013; 26(3): 334–342.
- Guo H, Lee JD, Uzui H, et al. Effects of heparin on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Can J Cardiol. 2007; 23(4): 275–280.
- Tyagi N, Kandel M, Munjal C, et al. Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. J Orthop Res. 2011; 29(10): 1511–1516.
- Chaussalet M, Lamy E, Foucault-Bertaud A, et al. Homocysteine modulates the proteolytic potential of human vascular endothelial cells. Biochem Biophys Res Commun. 2004; 316(1): 170–176.
- Torres L, García-Trevijano ER, Rodríguez JA, et al. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. Biochim Biophys Acta. 1999; 1455(1): 12–22.
- Wang ZS, Jin H, Wang DM. Influence of hydrogen sulfide on zymogen activation of homocysteine-induced matrix metalloproteinase-2 in H9C2 cardiocytes. Asian Pac J Trop Med. 2016; 9(5): 489–493.
- Lee SJ, Lee YiS, Seo KW, et al. Homocysteine enhances MMP-9 production in murine macrophages via ERK and Akt signaling pathways. Toxicol Appl Pharmacol. 2012; 260(1): 89–94.
- Doronzo G, Russo I, Mattiello L, et al. Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways. Thromb Haemost. 2005; 94(6): 1285–1293.
- Tyagi SC, Meyer L, Schmaltz RA, et al. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis. 1995; 116(1): 43–57.
- Ke XD, Foucault-Bertaud A, Genovesio C, et al. Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism. Mol Cell Biochem. 2010; 335(1-2): 203–210.
- Mujumdar VS, Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem. 2001; 82(3): 491–500.
- Hofmann MA, Lalla E, Lu Y, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001; 107(6): 675–683.
